Publishing research using ab8021? Please let us know so that we can cite the reference in this datasheet.

ab8021 has been referenced in 18 publications.

  • Ali I  et al. Role of fractalkine-CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain. Neurobiol Dis 74:194-203 (2015). PubMed: 25461978
  • Ruchaya PJ  et al. The cardiovascular actions of fractalkine/CX3CL1 in the hypothalamic paraventricular nucleus are attenuated in rats with heart failure. Exp Physiol 99:111-22 (2014). Rat . PubMed: 24036597
  • Lee S  et al. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J Neurosci 34:12538-46 (2014). PubMed: 25209291
  • Wang X  et al. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Carcinogenesis 35:2283-90 (2014). PubMed: 25086759
  • Ryu JC  et al. Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia. Circulation 127:710-9 (2013). Mouse . PubMed: 23307829
  • Celesti G  et al. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis. Br J Cancer 109:2424-33 (2013). Human . PubMed: 24084767
  • Rivollier A  et al. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209:139-55 (2012). PubMed: 22231304
  • Kim M  et al. Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells. Mol Cancer Res 10:11-24 (2012). IHC-P, Flow Cyt ; Human . PubMed: 22064656
  • Donnelly DJ  et al. Deficient CX3CR1 Signaling Promotes Recovery after Mouse Spinal Cord Injury by Limiting the Recruitment and Activation of Ly6Clo/iNOS+ Macrophages. J Neurosci 31:9910-22 (2011). PubMed: 21734283
  • Pechenino AS  et al. Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol Genomics 43:1065-73 (2011). WB ; Rat . PubMed: 21750230
  • Clements D  et al. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma. J Immunol 185:1812-21 (2010). IHC-P ; Human . PubMed: 20585037
  • Erreni M  et al. Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer 46:3383-92 (2010). ICC/IF, IHC-P ; Human . PubMed: 20728344
  • Wang X  et al. Probiotic preparation VSL#3 alters the distribution and phenotypes of dendritic cells within the intestinal mucosa in C57BL/10J mice. J Nutr 139:1595-602 (2009). Flow Cyt ; Mouse . PubMed: 19549755
  • Ishida Y  et al. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 180:569-79 (2008). IHC-P ; Mouse . PubMed: 18097059
  • Patel A  et al. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Eur J Vasc Endovasc Surg 36:20-7 (2008). PubMed: 18296082
  • Andréasson U  et al. B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule. Cancer Lett 259:138-45 (2008). PubMed: 18060687
  • Marchesi F  et al. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res 68:9060-9 (2008). ICC/IF, IHC-P ; Human . PubMed: 18974152
  • Barlic J  et al. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms. J Biol Chem 279:48520-34 (2004). PubMed: 15347678